Electrophysiology

The cardiac subspecialty of electrophysiology (EP) diagnoses and treats arrhythmias. This includes use of pacemakers to treat bradycardia, implantable cardioverter defibrillators (ICD) for tachycardia, heart failure and patients at risk of sudden cardiac arrest, and cardiac ablation treatments to treat heart rhythm disorders.

mages of the Globe Pulsed Field System courtesy of Kardium

Cardiologist sees ‘tremendous potential’ in new-look PFA system

Updated data on a new PFA system from Kardium found that freedom from atrial arrhythmia after one year was 84.2% for paroxysmal AFib and 80% for persistent AFib.  

Video interview with Devi Nair, MD, who shares her experience of using the Sphere-9 PFA system in the FDA IDE late-breaking trial at HRS24. #HRS #PFA #HRS2024

All-in-one PFA system linked to positive safety profile, faster procedures

Devi Nair, MD, director of cardiac electrophysiology with St. Bernard's Heart and Vascular Center, discussed her experience using a new-look Medtronic pulsed field ablation (PFA) system to treat persistent AFib.

Video interview with Devi Nair, MD, who explains how to go fluoroless in PFA procedures. #HRS #HRS24 #HRS2024 #0Fluoro #zerofluoro #EPeeps

How to perform fluoroscopy-free PFA ablation procedures 

Pulsed field ablation is a hot new technology in electrophysiology, but its use of fluoroscopy is associated with certain challenges.

HRS president Jodie Hurwitz, MD, discusses trends in electrophysiology at the 2024 HRS meeting.

Exploring the biggest trends at HRS 2024

Heart Rhythm Society President Jodie Hurwitz, MD, told Cardiovascular Business that pulsed field ablation was one of the hottest topics at Heart Rhythm 2024. It may be early, she said, but the technology is already making an impact. 

WearLinq's eWave six-lead wearable ECG monitor

Wearable ECG specialists acquire new testing facility to reach more patients

San Francisco-based WearLinq says the acquisition will help its six-lead ECG technology reach more heart patients throughout the United States.   

The late-breaking U.S. multicenter admIRE clinical trial at the Heart Rhythm Society 2024 meeting, showed positive data on the long-term safety and effectiveness of the the Biosense Webster Varipulse pulsed field ablation (PFA) system in patients with paroxysmal atrial fibrillation. #HRS #HRS2024 #PFA

Biosense Webster Varipulse PFA system performs well with minimal adverse events

"This was the first PFA IDE study to support a substantial number of fluoro-free procedures," said presenter Vivek Reddy, MD.

Atraverse Medical Hotwire radiofrequency (RF) guidewire

Medical device startup gains FDA clearance for new RF guidewire, raises $12.5M

Atraverse Medical, a San Diego-based medical device company founded in 2022, designed the guidewire to give physicians as much freedom as possible while treating heart patients. 

Cardiology ranked No. 2 among all specialties with 122 FDA-cleared AI models

Only radiology is associated with more FDA-cleared AI algorithms than cardiology, according to new federal data.